NS-304 and placebo in patients with pulmonary arterial hypertension.

• Research type

  Research Study

• Full title

  A multi-centre, multinational, open-label, single dose hemodynamic study followed by a multi-centre, multinational randomised, double blind, parallel-group, placebo controlled study to assess the safety, tolerability, pharmacokinetics and preliminary efficacy (proof of concept) of NS-304 in the treatment of pulmonary arterial hypertension in subjects aged 18 years and over.

• Contact name

  Simon J S Gibbs

• Contact email

  s.gibbs@imperial.ac.uk

• Sponsor organisation

  Nippon Shinyaku Co.,Ltd

• Eudract number

  2007-003328-39

• ISRCTN Number

  not known

• REC name

  London - Fulham Research Ethics Committee

• REC reference

  08/H0711/74

• Date of REC Opinion

  5 Nov 2008

• REC opinion

  Further Information Favourable Opinion